Chimeric antigen receptors targeting cd70
The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic m...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; heb |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Mathilde Brunnhilde DUSSEAUX Siler PANOWSKI Tao SAI Roman Ariel GALETTO Barbra Johnson SASU Niranjana Aditi NAGARAJAN Yoon PARK Surabhi SRIVATSA SRINIVASAN Thomas John VAN BLARCOM |
| description | The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_IL276396A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>IL276396A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_IL276396A3</originalsourceid><addsrcrecordid>eNrjZNB0zsjMTS3KTFZIzCvJTE_NUyhKTU4tKMkvKlYoSSxKTy3JzEtXSE4xN-BhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGePkbmZsaWZo7GBBUAAAbgJ0g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Chimeric antigen receptors targeting cd70</title><source>esp@cenet</source><creator>Mathilde Brunnhilde DUSSEAUX ; Siler PANOWSKI ; Tao SAI ; Roman Ariel GALETTO ; Barbra Johnson SASU ; Niranjana Aditi NAGARAJAN ; Yoon PARK ; Surabhi SRIVATSA SRINIVASAN ; Thomas John VAN BLARCOM</creator><creatorcontrib>Mathilde Brunnhilde DUSSEAUX ; Siler PANOWSKI ; Tao SAI ; Roman Ariel GALETTO ; Barbra Johnson SASU ; Niranjana Aditi NAGARAJAN ; Yoon PARK ; Surabhi SRIVATSA SRINIVASAN ; Thomas John VAN BLARCOM</creatorcontrib><description>The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).</description><language>eng ; heb</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200930&DB=EPODOC&CC=IL&NR=276396A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200930&DB=EPODOC&CC=IL&NR=276396A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Mathilde Brunnhilde DUSSEAUX</creatorcontrib><creatorcontrib>Siler PANOWSKI</creatorcontrib><creatorcontrib>Tao SAI</creatorcontrib><creatorcontrib>Roman Ariel GALETTO</creatorcontrib><creatorcontrib>Barbra Johnson SASU</creatorcontrib><creatorcontrib>Niranjana Aditi NAGARAJAN</creatorcontrib><creatorcontrib>Yoon PARK</creatorcontrib><creatorcontrib>Surabhi SRIVATSA SRINIVASAN</creatorcontrib><creatorcontrib>Thomas John VAN BLARCOM</creatorcontrib><title>Chimeric antigen receptors targeting cd70</title><description>The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB0zsjMTS3KTFZIzCvJTE_NUyhKTU4tKMkvKlYoSSxKTy3JzEtXSE4xN-BhYE1LzClO5YXS3Axybq4hzh66qQX58anFBYnJqXmpJfGePkbmZsaWZo7GBBUAAAbgJ0g</recordid><startdate>20200930</startdate><enddate>20200930</enddate><creator>Mathilde Brunnhilde DUSSEAUX</creator><creator>Siler PANOWSKI</creator><creator>Tao SAI</creator><creator>Roman Ariel GALETTO</creator><creator>Barbra Johnson SASU</creator><creator>Niranjana Aditi NAGARAJAN</creator><creator>Yoon PARK</creator><creator>Surabhi SRIVATSA SRINIVASAN</creator><creator>Thomas John VAN BLARCOM</creator><scope>EVB</scope></search><sort><creationdate>20200930</creationdate><title>Chimeric antigen receptors targeting cd70</title><author>Mathilde Brunnhilde DUSSEAUX ; Siler PANOWSKI ; Tao SAI ; Roman Ariel GALETTO ; Barbra Johnson SASU ; Niranjana Aditi NAGARAJAN ; Yoon PARK ; Surabhi SRIVATSA SRINIVASAN ; Thomas John VAN BLARCOM</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_IL276396A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; heb</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Mathilde Brunnhilde DUSSEAUX</creatorcontrib><creatorcontrib>Siler PANOWSKI</creatorcontrib><creatorcontrib>Tao SAI</creatorcontrib><creatorcontrib>Roman Ariel GALETTO</creatorcontrib><creatorcontrib>Barbra Johnson SASU</creatorcontrib><creatorcontrib>Niranjana Aditi NAGARAJAN</creatorcontrib><creatorcontrib>Yoon PARK</creatorcontrib><creatorcontrib>Surabhi SRIVATSA SRINIVASAN</creatorcontrib><creatorcontrib>Thomas John VAN BLARCOM</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Mathilde Brunnhilde DUSSEAUX</au><au>Siler PANOWSKI</au><au>Tao SAI</au><au>Roman Ariel GALETTO</au><au>Barbra Johnson SASU</au><au>Niranjana Aditi NAGARAJAN</au><au>Yoon PARK</au><au>Surabhi SRIVATSA SRINIVASAN</au><au>Thomas John VAN BLARCOM</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Chimeric antigen receptors targeting cd70</title><date>2020-09-30</date><risdate>2020</risdate><abstract>The disclosure provides CARs (CARs) that specifically bind to CD70. The disclosure further relates to engineered immune cells comprising such CARs, CAR-encoding nucleic acids, and methods of making such CARs, engineered immune cells, and nucleic acids. The disclosure further relates to therapeutic methods for use of these CARs and engineered immune cells comprising these CARs for the treatment of a condition associated with malignant cells expressing CD70 (e.g., cancer).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; heb |
| recordid | cdi_epo_espacenet_IL276396A |
| source | esp@cenet |
| title | Chimeric antigen receptors targeting cd70 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T20%3A59%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Mathilde%20Brunnhilde%20DUSSEAUX&rft.date=2020-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EIL276396A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |